Active and Non-Active Comparators Yield Different Estimates of the Association Between Proton Pump Inhibitor Use and Recorded Mortality During Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.

Ihara Y, Okada N, Mizutani M, Nakamura Y, Shimomura Y, Yamamoto S

Open source

DOI
10.1002/pds.70478
Published
2026 Sep
Container
Pharmacoepidemiology and drug safety
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pds.70478,
  title = {Active and Non-Active Comparators Yield Different Estimates of the Association Between Proton Pump Inhibitor Use and Recorded Mortality During Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.},
  author = {Ihara Y and Okada N and Mizutani M and Nakamura Y and Shimomura Y and Yamamoto S},
  year = {2026},
  journal = {Pharmacoepidemiology and drug safety},
  doi = {10.1002/pds.70478},
  url = {https://doi.org/10.1002/pds.70478}
}

RIS

TY  - JOUR
TI  - Active and Non-Active Comparators Yield Different Estimates of the Association Between Proton Pump Inhibitor Use and Recorded Mortality During Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.
AU  - Ihara Y
AU  - Okada N
AU  - Mizutani M
AU  - Nakamura Y
AU  - Shimomura Y
AU  - Yamamoto S
PY  - 2026
JO  - Pharmacoepidemiology and drug safety
DO  - 10.1002/pds.70478
UR  - https://doi.org/10.1002/pds.70478
ER  - 

APA

Y, I., N, O., M, M., Y, N., Y, S., & S, Y. (2026). Active and Non-Active Comparators Yield Different Estimates of the Association Between Proton Pump Inhibitor Use and Recorded Mortality During Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.. Pharmacoepidemiology and drug safety. https://doi.org/10.1002/pds.70478

Source records